EEG / EMG in Vermont

DEYMED Diagnostic is a Czech-headquartered manufacturer of advanced neurophysiology and psychiatry diagnostic and treatment systems, operating since 1997. The company designs and manufactures EEG (electroencephalography), EMG (electromyography), PSG (polysomnography), TMS (transcranial magnetic stimulation), and biofeedback systems for clinical and research applications. Products are distributed across 60+ countries with over 12,000 units installed globally. All devices are engineered to ISO 13485 and FDA 21 CFR Part 820 quality management standards, comply with EN 60601 safety requirements, and carry CE marking. The company operates a multi-functional product portfolio: TruScan EEG for portable, clinical, and long-term monitoring; TruTrace EMG for nerve conduction studies, electromyography, and autonomic nervous system assessment (battery-powered, configurable as cart or portable); SomniPro PSG for sleep studies; DuoMAG rTMS/TMS systems (monophasic and biphasic variants) for clinical and research brain stimulation; and BrainFeedback/neurofeedback systems for neurotraining. The company emphasizes close collaboration with clinical specialists during development, strict quality testing, and comprehensive technical support including remote assistance tools. Service and support are available Monday–Friday, 8:00–17:00 CET, with both quick and unattended remote support applications provided. Systems are designed to run on Windows 7 through Windows 10 on standard desktop or laptop hardware.

Head Diagnostics Ltd is an Irish medtech company specializing in clinically validated AI-driven digital solutions for neurological assessment and brain health management. The company develops cloud-based software platforms and handheld medical devices focused on cognitive assessment, neuropsychological testing, and brainstem function evaluation. Primary product: HDx Cognition (formerly IntelliSpace Cognition, originally developed by Philips) is a cloud-based Software-as-a-Service platform for comprehensive, digitized neuropsychological assessment across six cognitive domains. The platform comprises a patient tablet interface and clinician PC/tablet interface, delivering immediate scoring, normative comparisons, and automated reporting. Assessments align with established neuropsychological measures and have been clinically validated through multiple U.S. clinical trials on demographically representative populations. Secondary product: iTremor is a handheld, non-invasive device using laser speckle metrology to measure Ocular Microtremor (OMT) as an indicator of brainstem function. It delivers objective neurological insights in three seconds; currently restricted to research use (not FDA cleared). The company targets clinical workflows in neurology, geriatrics, and memory clinics, supporting assessment and monitoring of mild cognitive impairment, dementia, Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, and traumatic brain injury. HDx Cognition is normed on large U.S. populations and demonstrates reliability and equivalence to traditional paper-based testing. The platform integrates with electronic health records and enables longitudinal patient monitoring and remote assessment with clinician oversight. Certifications and recognition: Red Dot Award (2020), iF Design Award (2020), UX Design Award (2020), 2023 AI in Healthcare Award, 2024 Irish Medtech Awards finalist, and George Sigerson Award (2024). Technology is grounded in decades of cognitive science research and developed in collaboration with leading clinicians, hospitals, universities, and research centers.